N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine

C108H107N37O5 — CID 160770217

IUPACN-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESCC(C)Oc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC1CCC(=O)N1c1nn(C)c2cc(Nc3c[nH]c4cccnc34)ccc12.COc1ccc2[nH]nc(Nc3ccc4c(C5CC5)nn(C)c4c3)c2n1.Cc1cc(COc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)on1.Cn1nc(C2CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21
InChIInChI=1S/C20H20N6O.C19H17N7O2.C18H18N6O.C17H18N6O.C17H16N6.C17H18N6/c1-12-5-8-18(27)26(12)20-14-7-6-13(10-17(14)25(2)24-20)23-16-11-22-15-4-3-9-21-19(15)16;1-11-8-13(28-25-11)10-27-19-14-6-5-12(9-16(14)26(2)24-19)21-18-17-15(22-23-18)4-3-7-20-17;1-24-14-9-11(5-6-12(14)16(23-24)10-3-4-10)19-18-17-13(21-22-18)7-8-15(20-17)25-2;1-10(2)24-17-12-7-6-11(9-14(12)23(3)22-17)19-16-15-13(20-21-16)5-4-8-18-15;1-23-14-9-11(6-7-12(14)15(22-23)10-4-5-10)19-17-13-3-2-8-18-16(13)20-21-17;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16/h3-4,6-7,9-12,22-23H,5,8H2,1-2H3;3-9H,10H2,1-2H3,(H2,21,22,23);5-10H,3-4H2,1-2H3,(H2,19,21,22);4-10H,1-3H3,(H2,19,20,21);2-3,6-10H,4-5H2,1H3,(H2,18,19,20,21);4-10H,1-3H3,(H2,19,20,21)
InChIKeyRZFHORRFHODALR-UHFFFAOYSA-N
MW2003.30 g/mol
LogP21.20
Rot. Bonds22

About N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine

N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine (PubChem CID 160770217) has the molecular formula C108H107N37O5 and a molecular weight of 2003.30 g/mol. Its IUPAC name is N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine.

Molecular Properties

Compound NameN-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
PubChem CID160770217
Molecular FormulaC108H107N37O5
Molecular Weight2003.30 g/mol
Exact Mass2001.93
IUPAC NameN-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine
SMILESCC(C)Oc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC1CCC(=O)N1c1nn(C)c2cc(Nc3c[nH]c4cccnc34)ccc12.COc1ccc2[nH]nc(Nc3ccc4c(C5CC5)nn(C)c4c3)c2n1.Cc1cc(COc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)on1.Cn1nc(C2CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21
InChIInChI=1S/C20H20N6O.C19H17N7O2.C18H18N6O.C17H18N6O.C17H16N6.C17H18N6/c1-12-5-8-18(27)26(12)20-14-7-6-13(10-17(14)25(2)24-20)23-16-11-22-15-4-3-9-21-19(15)16;1-11-8-13(28-25-11)10-27-19-14-6-5-12(9-16(14)26(2)24-19)21-18-17-15(22-23-18)4-3-7-20-17;1-24-14-9-11(5-6-12(14)16(23-24)10-3-4-10)19-18-17-13(21-22-18)7-8-15(20-17)25-2;1-10(2)24-17-12-7-6-11(9-14(12)23(3)22-17)19-16-15-13(20-21-16)5-4-8-18-15;1-23-14-9-11(6-7-12(14)15(22-23)10-4-5-10)19-17-13-3-2-8-18-16(13)20-21-17;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16/h3-4,6-7,9-12,22-23H,5,8H2,1-2H3;3-9H,10H2,1-2H3,(H2,21,22,23);5-10H,3-4H2,1-2H3,(H2,19,21,22);4-10H,1-3H3,(H2,19,20,21);2-3,6-10H,4-5H2,1H3,(H2,18,19,20,21);4-10H,1-3H3,(H2,19,20,21)
InChIKeyRZFHORRFHODALR-UHFFFAOYSA-N
XLogP21.20
TPSA489.66 Ų
H-Bond Donors12
H-Bond Acceptors35
Rotatable Bonds22
Heavy Atoms150
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002003.30
LogP ≤ 521.20
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1035

Analyze N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The IUPAC name of N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine (CID 160770217) is N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine.
What is the SMILES notation for N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The canonical SMILES for N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine is CC(C)Oc1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC(C)c1nn(C)c2cc(Nc3n[nH]c4cccnc34)ccc12.CC1CCC(=O)N1c1nn(C)c2cc(Nc3c[nH]c4cccnc34)ccc12.COc1ccc2[nH]nc(Nc3ccc4c(C5CC5)nn(C)c4c3)c2n1.Cc1cc(COc2nn(C)c3cc(Nc4n[nH]c5cccnc45)ccc23)on1.Cn1nc(C2CC2)c2ccc(Nc3[nH]nc4ncccc34)cc21.
What is the InChIKey of N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
The InChIKey is RZFHORRFHODALR-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H20N6O.C19H17N7O2.C18H18N6O.C17H18N6O.C17H16N6.C17H18N6/c1-12-5-8-18(27)26(12)20-14-7-6-13(10-17(14)25(2)24-20)23-16-11-22-15-4-3-9-21-19(15)16;1-11-8-13(28-25-11)10-27-19-14-6-5-12(9-16(14)26(2)24-19)21-18-17-15(22-23-18)4-3-7-20-17;1-24-14-9-11(5-6-12(14)16(23-24)10-3-4-10)19-18-17-13(21-22-18)7-8-15(20-17)25-2;1-10(2)24-17-12-7-6-11(9-14(12)23(3)22-17)19-16-15-13(20-21-16)5-4-8-18-15;1-23-14-9-11(6-7-12(14)15(22-23)10-4-5-10)19-17-13-3-2-8-18-16(13)20-21-17;1-10(2)15-12-7-6-11(9-14(12)23(3)22-15)19-17-16-13(20-21-17)5-4-8-18-16/h3-4,6-7,9-12,22-23H,5,8H2,1-2H3;3-9H,10H2,1-2H3,(H2,21,22,23);5-10H,3-4H2,1-2H3,(H2,19,21,22);4-10H,1-3H3,(H2,19,20,21);2-3,6-10H,4-5H2,1H3,(H2,18,19,20,21);4-10H,1-3H3,(H2,19,20,21).
What are the key properties of N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine?
N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine has a molecular weight of 2003.30 g/mol, XLogP of 21.20, 22 rotatable bonds, 12 hydrogen bond donors, and 35 hydrogen bond acceptors.
Where does this data come from?
All data for N-(3-cyclopropyl-1-methylindazol-6-yl)-5-methoxy-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(3-cyclopropyl-1-methylindazol-6-yl)-2H-pyrazolo[3,4-b]pyridin-3-amine;N-[1-methyl-3-[(3-methyl-1,2-oxazol-5-yl)methoxy]indazol-6-yl]-1H-pyrazolo[4,3-b]pyridin-3-amine;5-methyl-1-[1-methyl-6-(1H-pyrrolo[3,2-b]pyridin-3-ylamino)indazol-3-yl]pyrrolidin-2-one;N-(1-methyl-3-propan-2-ylindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine;N-(1-methyl-3-propan-2-yloxyindazol-6-yl)-1H-pyrazolo[4,3-b]pyridin-3-amine is sourced from PubChem (CID 160770217), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).